Opus Capital Group, LLC Pfizer Inc Transaction History

Opus Capital Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $422,643 - $512,729	-14,032 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $111,687 - $159,577	-4,132 Reduced 22.75%	14,032 $458,000
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $186,063 - $211,158	-5,652 Reduced 23.73%	18,164 $712,000
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $75,799 - $98,289	2,333 Added 10.86%	23,816 $856,000
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $115,007 - $129,127	3,110 Added 16.93%	21,483 $931,000
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $61,701 - $74,839	-1,790 Reduced 8.88%	18,373 $810,000
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $20,262 - $23,507	-635 Reduced 3.05%	20,163 $716,000
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $8,315 - $8,822	-250 Reduced 1.19%	20,798 $754,000
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $652,488 - $718,789	21,048	21,048 $751,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.